$3.700
-0.010 (-0.27%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による SABS の予測・予想
Alphio's SABS stock price prediction model matches the current SAB Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.78 (+2.06%). The 1-week path is $3.76 (+1.67%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
SAB Biotherapeutics Inc 株は買うべき？
SAB Biotherapeutics Inc is a good buy right now due to its current price of $3.79, which is significantly lower than the average analyst price target of $12.75, suggesting a potential upside of over 235%. Additionally, the company has a strong cash position of $217.6 million, providing operational runway through 2028 despite recent losses. However, the main risk is the net loss of $22.49 million reported in Q2 2026, which highlights ongoing financial challenges.
SABS の株価は Tuesday に $3.70 で引け、その前に下落 -0.27%
SAB Biotherapeutics Inc (SABS) last closed at $3.7, losing -0.27%. These facts feed the 1-day and 1-week SABS price prediction above.
予想の要因
SAB Biotherapeutics Inc（SABS）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが SABS に最も近い銘柄を、類似度順に表示します。
SABS の季節性分析
Historically the probability of a positive September return for SABS is 0.00%. December offers the highest probability of a positive month at 37.21%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。